Sientra AlloX2短期病例研究、手术技巧与圆桌讨论
本文由3位术者报告40例初次乳房再造患者使用AlloX2乳房组织扩张器的短期病例经验与手术技巧。随访约6个月,最常见并发症为血清肿,多数病例成功经第二港抽吸假体周围积液。作者认为AlloX2治疗血清肿成功,应被视为植入物乳房再造常见并发症的无创治疗工具。
要点
- AlloX2扩张器含第二港,可经皮与假体周围腔隙沟通并引流积液。
- 40例初次乳房再造患者中,最常见并发症为血清肿,多数经第二港成功引流。
- 作者认为AlloX2治疗血清肿成功,应被视为植入物乳房再造常见并发症的无创治疗工具。
核心结论
- AlloX2在治疗血清肿方面已获成功,作者认为应被视为植入物乳房再造常见并发症的无创治疗工具。
研究设计与样本
- 本文提供3位使用AlloX2的术者在初次乳房再造患者中的短期病例研究与手术技巧。
- 3位术者为40例初次再造患者植入AlloX2,随访约6个月,按标准诊疗进行。
- 所有植入AlloX2的患者均接受即刻再造,仅1例为延期再造。
主要发现
- 患者经历的最常见并发症为血清肿。
- 多数病例中,术者成功使用第二港引流假体周围积液。
临床怎么用
- 作者认为AlloX2应被视为植入物乳房再造常见并发症的无创治疗工具。
- 3位背景与技术各异的术者提供了各自的手术与术后管理经验及建议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The AlloX2 Breast Tissue Expander (Sientra, Santa Barbara, Calif.) is a unique device that contains a second port to allow for transdermal communication with the pocket around the implant. The injection dome of this expander contains two ports; one is used for traditional saline injection, and a new second port facilitates fluid drainage from the periprosthetic space through an integral drain. The AlloX2 allows for the treatment of seromas and diagnostic fluid sampling to identify bacteria and hone antibiotic treatment in the setting of periprosthetic infection. This device has a significant advantage over traditional expanders, given that seromas and infections are the most common complications in implant-based breast reconstruction, with or without the use of soft-tissue support matrix. METHODS: This article provides short-term case studies and surgical pearls from 3 surgeons who utilize the AlloX2 in primary breast reconstruction patients. Three surgeons implanted 40 primary reconstruction patients with AlloX2. Follow-up was approximately 6 months, per the standard of care. All patients implanted with AlloX2 underwent immediate reconstruction, with the exception of 1 delayed reconstruction. RESULTS: The most common complications the patients experienced were seromas. In most cases, the surgeons successfully used the second port to drain periprosthetic fluid. CONCLUSIONS: The AlloX2 has been successful in treating seromas and should be considered a tool for noninvasive treatment of common complications of implant-based breast reconstruction. Three surgeons with varied backgrounds and techniques provide their surgical and postoperative management experiences and recommendations.
引用
- Zeidler KR, Capizzi PJ, Pittman TA, et al. Sientra AlloX2 Short-Term Case Study, Surgical Pearls, and Roundtable Discussion. Plast Reconstr Surg. 2018. PMID: 29595716. doi:10.1097/PRS.0000000000004352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。